29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

The current study's objective is to create and evaluate an effervescent-based sustained-release floating drug delivery system (FDDS) for carvedilol that has a 12-hour dissolving time to reduce the frequency of its administration. Over the past 20 years, there has been a huge desire for more dosage forms that are acceptable to patients. Because of this, their technologies are more in demand than ever. Since creating a new chemical entity is very expensive, pharmaceutical companies are focusing on creating novel drug delivery systems for their existing medications that have improved efficacy and…mehr

Produktbeschreibung
The current study's objective is to create and evaluate an effervescent-based sustained-release floating drug delivery system (FDDS) for carvedilol that has a 12-hour dissolving time to reduce the frequency of its administration. Over the past 20 years, there has been a huge desire for more dosage forms that are acceptable to patients. Because of this, their technologies are more in demand than ever. Since creating a new chemical entity is very expensive, pharmaceutical companies are focusing on creating novel drug delivery systems for their existing medications that have improved efficacy and bioavailability, along with a lower dose frequency to lessen side effects.
Autorenporträt
O Dr. Prasanta Kumar Mohapatra licenciou-se no Instituto de Farmácia e Tecnologia de Salipur, Odisha, e obteve o seu mestrado em Farmácia no Instituto de Ciências Farmacêuticas Kanak Manjari de Rourkela, tendo obtido o seu doutoramento no Departamento de Ciências Farmacêuticas da Universidade de Utkal (UDPS), situada em Vani Vihar, Bhubaneswar, Orissa, Índia, em 2014.